Happi Staff11.20.20
INOLEX is listing the company’s 6.2-acre property located on South Swanson Street in Philadelphia, PA for sale on the commercial real estate market.
The site sale marks a continuation of the company’s long-term growth strategy as a provider of natural, sustainable, and innovative ingredients for health, beauty, and wellness.
In 2019, the company set in motion the transition of its US production platform to a new flagship manufacturing facility in Charlotte, NC. With steady operations in Charlotte and a unified global team, company officials say the firm is well positioned to continue its long-term growth momentum.
“Establishing robust manufacturing capabilities in Charlotte was a generational move to anticipate and serve global demand,” said David Plimpton, CEO and president. “Likewise, the divestiture of the Philadelphia site is the next important step in our long-term growth plans that reflects our entrepreneurial, innovative spirit as a company.”
The company intends to maintain a strong presence in the greater Philadelphia region to continue to serve its customers and partners. The company contends that concurrent to the sale of the site, the company is evaluating new offices and lab space in the greater Philadelphia region.
The site sale marks a continuation of the company’s long-term growth strategy as a provider of natural, sustainable, and innovative ingredients for health, beauty, and wellness.
"Since inception, INOLEX has been a company that has adapted and evolved to remain relevant in the market. We now have an opportunity to deploy our deep technical expertise as both a designer and a manufacturer of ingredients with space, equipment, and means for innovation that will serve us and our customers for years to come,” said Plimpton.
The site sale marks a continuation of the company’s long-term growth strategy as a provider of natural, sustainable, and innovative ingredients for health, beauty, and wellness.
In 2019, the company set in motion the transition of its US production platform to a new flagship manufacturing facility in Charlotte, NC. With steady operations in Charlotte and a unified global team, company officials say the firm is well positioned to continue its long-term growth momentum.
“Establishing robust manufacturing capabilities in Charlotte was a generational move to anticipate and serve global demand,” said David Plimpton, CEO and president. “Likewise, the divestiture of the Philadelphia site is the next important step in our long-term growth plans that reflects our entrepreneurial, innovative spirit as a company.”
The company intends to maintain a strong presence in the greater Philadelphia region to continue to serve its customers and partners. The company contends that concurrent to the sale of the site, the company is evaluating new offices and lab space in the greater Philadelphia region.
The site sale marks a continuation of the company’s long-term growth strategy as a provider of natural, sustainable, and innovative ingredients for health, beauty, and wellness.
"Since inception, INOLEX has been a company that has adapted and evolved to remain relevant in the market. We now have an opportunity to deploy our deep technical expertise as both a designer and a manufacturer of ingredients with space, equipment, and means for innovation that will serve us and our customers for years to come,” said Plimpton.